Long-term results of single-procedure catheter ablation for atrial fibrillationin pre- and post-menopausal women

Journal of Geriatric Cardiology

Volumn 11, Issue 2, 2014, Pages 120-125

  Lin, Tao ^a   Du, Xing ^a   Bai, Rong ^a   Chen, Ying Wei ^a   Yu, Rong Hui ^a   Long, De Yong ^a   Tang, Ri Bo ^a   Sang, Cai Hua ^a   Li, Song Nan ^a   Ma, Chang Sheng ^a   Dong, Jian Zeng ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Atrial fibrillation; Catheter ablation; Follow up; Menopausal woman

Indexed keywords

ANTIARRHYTHMIC AGENT; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ADULT; ANTICOAGULATION; ARTICLE; CATHETER; CATHETER ABLATION; CATHETER SHEATH; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG WITHDRAWAL; EMBOLISM; FEMALE; FLUOROSCOPY; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TAMPONADE; HUMAN; HYPERTENSION; LONG TERM CARE; MAJOR CLINICAL STUDY; MIDDLE AGED; MITRAL VALVE REGURGITATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PATIENT SAFETY; PERICARDIOCENTESIS; POSTMENOPAUSE; PREMENOPAUSE; PULMONARY VEIN ISOLATION; PULMONARY VEIN OBSTRUCTION; RADIOFREQUENCY; RECURRENT DISEASE; RETROSPECTIVE STUDY; SINUS RHYTHM; SMOKING; TACHYCARDIA;

EID: 84904504764     PISSN: 16715411     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1671-5411.2014.02.005     Document Type: Article

References (31)

1. Calkins H, Kuck KH, Cappato R, et al. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace 2012; 14: 528-606.
2. Gowd BM, Thompson PD. Effect of female sex on cardiac arrhythmias. Cardiol Rev 2012; 20: 297-303.
3. Insulander P, Vallin H. Arrhythmias-sex differences in occurrence, symptomatology and management. Läkartidningen 2010; 107: 2006-2010.
4. Bailey MS, Curtis AB. The effects of hormones on arrhythmias in women. Curr Womens Health Rep 2002; 2:83-88.
5. Rienstra M, Van Veldhuisen DJ, Hagens VE, et al. Gender-related differences in rhythm control treatment in persistent atrial fibrillation: data of the Rate Control Versus Electrical Cardioversion (RACE) Study. J Am Coll Cardiol2005; 46: 1298-1306. (Pubitemid 41615553)
6. Shiroshita-Takeshita A, BrundelBJ, NattelS.Atrial fibrillation: basic mechanisms, remodeling and triggers. J Interv Card Electrophysiol 2005; 13: 181-193. (Pubitemid 41372065)
7. Franken RA, Rosa RF, Santos SC. Atrial fibrillation in the elderly. J Geriatr Cardiol2012; 9: 91-100.
8. Curtis AB, Narasimha D. Arrhythmias in women. Clin Cardiol2012; 35: 166-171.
9. Shigematsu R, Okura T, Kumagai S, et al. Cutoff and target values for intra-abdominal fat area for prevention of metabolic disorders in pre- and post-menopausal obese women before and after weight reduction. Circ J 2006; 70: 110-114. (Pubitemid 43021243)
10. Cosedis Nielsen J, Johannessen A, Raatikainen P, et al. Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation. N Engl J Med2012; 367: 1587-1595.
11. Navarrete A, Conte F, Moran M, et al. Ablation of atrial fibrillation at the time of cavotricuspid isthmus ablation in patients with atrial flutter without documented atrial fibrillation derives a better long-term benefit. J Cardiovasc Electrophysiol 2011; 22: 34-38.
12. Kurotobi T, Iwakura K, Inoue K, et al. Electrophysiological features of atrial tachyarrhythmias after the creation of a left atrial roof line during catheter ablation of atrial fibrillation.Int Heart J 2011; 52: 92-97.
13. Krummen DE, Narayan SM. Ablating persistent atrial fibrillation successfully. Curr Cardiol Rep 2012; 14: 563-570.
14. Di Biase L, Santangeli P, Natale A. How to ablate long-standing persistent atrial fibrillation? Curr Opin Cardiol 2013; 28: 26-35.
15. Crandall CJ, Barrett-Connor E. Endogenous sex steroid levels and cardiovascular disease in relation to the menopause: a systematic review. Endocrinol Metab Clin North Am 2013; 42: 227-253.
16. Patel D, Mohanty P, Di Biase L, et al. The impact of statins and renin-angiotensin-aldosterone system blockers on pulmonary vein antrum isolation outcomes in post-menopausal females. Europace 2010; 12: 322-330.
17. Sugishita K, Uchida M, Ikeda M. Gender difference in subjective symptoms related to paroxysmal atrial fibrillation is also detected in postmenopausal women. Int Heart J 2005; 46: 669-678.
18. Perez MV, Wang PJ, Larson JC, et al. Risk factors for atrial fibrillation and their population burden in postmenopausal women: the Women's Health Initiative Observational Study. Heart 2013; 99: 1173-1178.
19. Sugishita K, Uchida M, Ikeda M. Gender difference in subjective symptoms related to paroxysmal atrial fibrillation is also detected in postmenopausal women. Int Heart J2005; 46: 669-678.
20. Forleo GB, Tondo C, De Luca L, et al. Gender-related differences in catheter ablation of atrial fibrillation. Europace 2007; 9: 613-620. (Pubitemid 47263791)
21. Roten L, Rimoldi SF, Schwick N, et al. Gender differences in patients referred for atrial fibrillation management to a tertiary center. Pacing Clin Electrophysiol 2009; 32: 622-626.
22. Kurokawa J, Furukawa T. Non-genomic action of sex steroid hormones and cardiac repolarization. Biol Pharm Bull 2013; 36: 8-12.
23. 2+]i during metabolic inhibition. J Mol Cell Cardiol 2003; 35: 331-336.
24. Chen YI, Lee SH, Hsieh MH, et al. Effects of 17β-estradiol on tachycardia-induced changes of atrial refractoriness and cisapride-induced ventricular arrhythmia. J Cardiovasc Electrophysiol1999; 10: 587-598.
25. Van Noord C, Rodenburg EM, Stricker BH. Invited commentary: sex-steroid hormones and QT-interval duration. Am J Epidemiol 2011; 174: 412-415.
26. 2+ channel Cav1.2. Biochem Biophys Res Commun2007; 361: 522-527.
27. Chen J, Yang S, Hu S, et al. Estrogen prevents intestinal inflammation after trauma-hemorrhage via downregulation of angiotensin II and angiotensin II subtype I receptor. Am J Physiol Gastrointest Liver Physiol 2008; 295: G1131-G1137.
28. Rodriguez-Perez AI, Valenzuela R, Villar-Cheda B, et al. Estrogen and angiotensin interaction in the substantia nigra. Relevance to postmenopausal Parkinson's disease. Exp Neurol 2010; 224: 517-526.
29. Liu H, Yang L, Jin MW, et al. The selective estrogen receptor modulator raloxifene inhibits cardiac delayed rectifier potassium currents and voltage-gated sodium current without QTc interval prolongation. Pharmacol Res 2010; 62: 384-390.
30. Schotten U, Verheule S, Kirchhof P, et al. Pathophysiological mechanisms of atrial fibrillation: A translational appraisal. Physiol Rev 2011; 91: 265-325.
31. Lewalter T, Dobreanu D, Proclemer A,et al.Atrial fibrillation ablation techniques. Europace2012; 14: 1515-1517.